Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration

Naoki Yahata, Shigeki Yuasa, Toshiyuki Araki

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

Studies of naturally occurring mutant mice, wlds, showing delayed Wallerian degeneration phenotype, suggest that axonal degeneration is an active process.We previously showed that increased nicotinamide adenine dinucleotide (NAD)-synthesizing activity by overexpression of nicotinamide mononucleotide adenylyltransferase (NMNAT) is the essential component of the Wlds protein, the expression of which is responsible for the delayed Wallerian degeneration phenotype in wlds mice. Indeed, NMNAT overexpression in cultured neurons provides robust protection to neurites, as well. To examine the effect of NMNAT overexpression in vivo and to analyze the mechanism that causes axonal protection, we generated transgenic mice (Tg) overexpressing NMNAT1 (nuclear isoform), NMNAT3 (mitochondrial isoform), or the Wlds protein bearing a W258A mutation, which disrupts NAD-synthesizing activity of the Wlds protein. Wallerian degeneration delay in NMNAT3-Tg was similar to that in wlds mice, whereas axonal protection in NMNAT1-Tg or Wlds(W258A)-Tg was not detectable. Detailed analysis of subcellular localization of the overexpressed proteins revealed that the axonal protection phenotype was correlated with localization of NMNAT enzymatic activity to mitochondrial matrix. Furthermore, we found that isolated mitochondria from mice showing axonal protection expressed unchanged levels of respiratory chain components, but were capable of increased ATP production. These results suggest that axonal protection by NMNAT expression in neurons is provided by modifying mitochondrial function. Alteration of mitochondrial function may constitute a novel tool for axonal protection, as well as a possible treatment of diseases involving axonopathy.

Original languageEnglish
Pages (from-to)6276-6284
Number of pages9
JournalJournal of Neuroscience
Volume29
Issue number19
DOIs
Publication statusPublished - 13-05-2009

Fingerprint

Nicotinamide-Nucleotide Adenylyltransferase
Wallerian Degeneration
Phenotype
NAD
Protein Isoforms
Proteins
Neurons
Neurites
Electron Transport
Transgenic Mice
Mitochondria
Adenosine Triphosphate
Mutation

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

@article{d6fe79335e0940d7a586605a49c06e95,
title = "Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration",
abstract = "Studies of naturally occurring mutant mice, wlds, showing delayed Wallerian degeneration phenotype, suggest that axonal degeneration is an active process.We previously showed that increased nicotinamide adenine dinucleotide (NAD)-synthesizing activity by overexpression of nicotinamide mononucleotide adenylyltransferase (NMNAT) is the essential component of the Wlds protein, the expression of which is responsible for the delayed Wallerian degeneration phenotype in wlds mice. Indeed, NMNAT overexpression in cultured neurons provides robust protection to neurites, as well. To examine the effect of NMNAT overexpression in vivo and to analyze the mechanism that causes axonal protection, we generated transgenic mice (Tg) overexpressing NMNAT1 (nuclear isoform), NMNAT3 (mitochondrial isoform), or the Wlds protein bearing a W258A mutation, which disrupts NAD-synthesizing activity of the Wlds protein. Wallerian degeneration delay in NMNAT3-Tg was similar to that in wlds mice, whereas axonal protection in NMNAT1-Tg or Wlds(W258A)-Tg was not detectable. Detailed analysis of subcellular localization of the overexpressed proteins revealed that the axonal protection phenotype was correlated with localization of NMNAT enzymatic activity to mitochondrial matrix. Furthermore, we found that isolated mitochondria from mice showing axonal protection expressed unchanged levels of respiratory chain components, but were capable of increased ATP production. These results suggest that axonal protection by NMNAT expression in neurons is provided by modifying mitochondrial function. Alteration of mitochondrial function may constitute a novel tool for axonal protection, as well as a possible treatment of diseases involving axonopathy.",
author = "Naoki Yahata and Shigeki Yuasa and Toshiyuki Araki",
year = "2009",
month = "5",
day = "13",
doi = "10.1523/JNEUROSCI.4304-08.2009",
language = "English",
volume = "29",
pages = "6276--6284",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "19",

}

Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration. / Yahata, Naoki; Yuasa, Shigeki; Araki, Toshiyuki.

In: Journal of Neuroscience, Vol. 29, No. 19, 13.05.2009, p. 6276-6284.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration

AU - Yahata, Naoki

AU - Yuasa, Shigeki

AU - Araki, Toshiyuki

PY - 2009/5/13

Y1 - 2009/5/13

N2 - Studies of naturally occurring mutant mice, wlds, showing delayed Wallerian degeneration phenotype, suggest that axonal degeneration is an active process.We previously showed that increased nicotinamide adenine dinucleotide (NAD)-synthesizing activity by overexpression of nicotinamide mononucleotide adenylyltransferase (NMNAT) is the essential component of the Wlds protein, the expression of which is responsible for the delayed Wallerian degeneration phenotype in wlds mice. Indeed, NMNAT overexpression in cultured neurons provides robust protection to neurites, as well. To examine the effect of NMNAT overexpression in vivo and to analyze the mechanism that causes axonal protection, we generated transgenic mice (Tg) overexpressing NMNAT1 (nuclear isoform), NMNAT3 (mitochondrial isoform), or the Wlds protein bearing a W258A mutation, which disrupts NAD-synthesizing activity of the Wlds protein. Wallerian degeneration delay in NMNAT3-Tg was similar to that in wlds mice, whereas axonal protection in NMNAT1-Tg or Wlds(W258A)-Tg was not detectable. Detailed analysis of subcellular localization of the overexpressed proteins revealed that the axonal protection phenotype was correlated with localization of NMNAT enzymatic activity to mitochondrial matrix. Furthermore, we found that isolated mitochondria from mice showing axonal protection expressed unchanged levels of respiratory chain components, but were capable of increased ATP production. These results suggest that axonal protection by NMNAT expression in neurons is provided by modifying mitochondrial function. Alteration of mitochondrial function may constitute a novel tool for axonal protection, as well as a possible treatment of diseases involving axonopathy.

AB - Studies of naturally occurring mutant mice, wlds, showing delayed Wallerian degeneration phenotype, suggest that axonal degeneration is an active process.We previously showed that increased nicotinamide adenine dinucleotide (NAD)-synthesizing activity by overexpression of nicotinamide mononucleotide adenylyltransferase (NMNAT) is the essential component of the Wlds protein, the expression of which is responsible for the delayed Wallerian degeneration phenotype in wlds mice. Indeed, NMNAT overexpression in cultured neurons provides robust protection to neurites, as well. To examine the effect of NMNAT overexpression in vivo and to analyze the mechanism that causes axonal protection, we generated transgenic mice (Tg) overexpressing NMNAT1 (nuclear isoform), NMNAT3 (mitochondrial isoform), or the Wlds protein bearing a W258A mutation, which disrupts NAD-synthesizing activity of the Wlds protein. Wallerian degeneration delay in NMNAT3-Tg was similar to that in wlds mice, whereas axonal protection in NMNAT1-Tg or Wlds(W258A)-Tg was not detectable. Detailed analysis of subcellular localization of the overexpressed proteins revealed that the axonal protection phenotype was correlated with localization of NMNAT enzymatic activity to mitochondrial matrix. Furthermore, we found that isolated mitochondria from mice showing axonal protection expressed unchanged levels of respiratory chain components, but were capable of increased ATP production. These results suggest that axonal protection by NMNAT expression in neurons is provided by modifying mitochondrial function. Alteration of mitochondrial function may constitute a novel tool for axonal protection, as well as a possible treatment of diseases involving axonopathy.

UR - http://www.scopus.com/inward/record.url?scp=66049102890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66049102890&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.4304-08.2009

DO - 10.1523/JNEUROSCI.4304-08.2009

M3 - Article

C2 - 19439605

AN - SCOPUS:66049102890

VL - 29

SP - 6276

EP - 6284

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 19

ER -